Affiliation:
1. Departamento de Investigación en Polímeros y Materiales, Universidad de Sonora, Rosales y Encinas s/n, Col. Centro CP 83000. Hermosillo, Sonora, Mexico
2. Departamento de Ciencias Químico-Biológicas, Universidad de Sonora, Boulevard Luis Encinas y Rosales s/n, Hermosillo, Sonora 83000, Mexico
3. Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Av. Universidad No. 1001, Cuernavaca, Morelos 62209, Mexico
4. Centro de Investigaciones Químicas-IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad No. 1001, Cuernavaca, Morelos 62209, Mexico
Abstract
Background:
Despite advances for cancer treatment, it still remains a major worldwide public health problem.
Compounds derived from natural sources are important alternatives to combat this mortal disease. Berberine is an
isoquinoline alkaloid with a wide variety of pharmacological properties, including antiproliferative activity. Previously, we
have found that fatty acids also show antiproliferative activity against cancer cell lines.
Background:
Despite advances for cancer treatment, it still remains a major worldwide public health problem.
Compounds derived from natural sources are important alternatives to combat this mortal disease. Berberine is an
isoquinoline alkaloid with a wide variety of pharmacological properties, including antiproliferative activity. Previously, we
have found that fatty acids also show antiproliferative activity against cancer cell lines.
Objective:
To combine berberine and fatty acids, or carboxylic acids, in order to improve their antiproliferative properties.
Objective:
To combine berberine and fatty acids, or carboxylic acids, in order to improve their antiproliferative properties.
Methods:
We synthetized six new hybrid derivatives through a simple methylenedioxy group-cleavage method followed by
the reaction with fatty acids, or carboxylic acids. The structure of the compounds was elucidated by IR, NMR and HRMS.
The in vitro antiproliferative activity against four human cancer cell lines (HeLa, A-549, PC-3 and LS-180) and one normal
cell line (ARPE-19), was evaluated by the MTT method. Chemical structures were drawn using SPARTAN '08 software and
the conformational analysis was carried out with a molecular mechanic level of theory and the SYBIL force field. All
molecular structures were subjected to geometrical optimization at the semi-empirical method PM3. Molecular descriptors
were calculated using DRAGON 5.4 and SPARTAN ´08 programs.
Methods:
We synthetized six new hybrid derivatives through a simple methylenedioxy group-cleavage method followed by
the reaction with fatty acids, or carboxylic acids. The structure of the compounds was elucidated by IR, NMR and HRMS.
The in vitro antiproliferative activity against four human cancer cell lines (HeLa, A-549, PC-3 and LS-180) and one normal
cell line (ARPE-19), was evaluated by the MTT method. Chemical structures were drawn using SPARTAN '08 software and
the conformational analysis was carried out with a molecular mechanic level of theory and the SYBIL force field. All
molecular structures were subjected to geometrical optimization at the semi-empirical method PM3. Molecular descriptors
were calculated using DRAGON 5.4 and SPARTAN ´08 programs.
Results:
The geranic acid and berberine hybrid compound (6) improved the antiproliferative activity shown by natural
berberine, even more than the 16- to 18-carbon atoms fatty acids. Compound 6 showed IC50 values of 2.40 ± 0.60, 1.5 ±
0.24, 5.85 ± 1.07 and 5.44 ± 0.24 μM, against HeLa, A-549, PC-3 and LS-180 human cancer cell lines, respectively. Using
this information, we performed a quantitative structure-activity relationship (QSAR) of the hybrid molecules and found that
the molecular descriptors associated with the antiproliferative activity are: hydrophobic constant associated with substituents
(!(!) = 6.5), molecular volume descriptor (!"#!"#$%& ≈ 700 Å!), !!"#", number of rotatable bonds (!"#) and number
of 6-membered rings (!"06).
Results:
The geranic acid and berberine hybrid compound (6) improved the antiproliferative activity shown by natural
berberine, even more than the 16- to 18-carbon atoms fatty acids. Compound 6 showed IC50 values of 2.40 ± 0.60, 1.5 ±
0.24, 5.85 ± 1.07 and 5.44 ± 0.24 μM, against HeLa, A-549, PC-3 and LS-180 human cancer cell lines, respectively. Using
this information, we performed a quantitative structure-activity relationship (QSAR) of the hybrid molecules and found that
the molecular descriptors associated with the antiproliferative activity are: hydrophobic constant associated with substituents
(!(!) = 6.5), molecular volume descriptor (!"#!"#$%& ≈ 700 Å!), !!"#", number of rotatable bonds (!"#) and number
of 6-membered rings (!"06).
Conclusion:
The methylendioxy and methoxyl groups in berberine are important for the antiproliferative activity shown by
its derivatives. Better results in antiproliferative activity were obtained in compound 6 with the prenyl moiety. The QSAR
indicates that the molecular descriptors which associated positively with the antiproliferative activity are: hydrophobic
constant associated with substituents (! ! = 6.5), molecular volume descriptor (!"#!"#$%& ≈700 Å3) and !!"#". This
research gave the basis for the design and preparation of new, easily afforded molecules derived from berberine and
carboxylic acids, with improved antiproliferative activity.
Conclusion:
The methylendioxy and methoxyl groups in berberine are important for the antiproliferative activity shown by
its derivatives. Better results in antiproliferative activity were obtained in compound 6 with the prenyl moiety. The QSAR
indicates that the molecular descriptors which associated positively with the antiproliferative activity are: hydrophobic
constant associated with substituents (! ! = 6.5), molecular volume descriptor (!"#!"#$%& ≈700 Å3) and !!"#". This
research gave the basis for the design and preparation of new, easily afforded molecules derived from berberine and
carboxylic acids, with improved antiproliferative activity.
Funder
National Council for Science and Technology of Mexico
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Pharmacology,Molecular Medicine